BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 20826021)

  • 1. Patients with premature cardiovascular disease and a positive family history for cardiovascular disease are prone to recurrent events.
    Mulders TA; Meyer Z; van der Donk C; Kroon AA; Ferreira I; Stehouwer CD; Pinto-Sietsma SJ
    Int J Cardiol; 2011 Nov; 153(1):64-7. PubMed ID: 20826021
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A positive family history for premature cardiovascular disease identifies patients prone to recurrent arterial thrombotic events.
    Mulders TA; Maurissen LF; Meyer Z; Hameeteman M; van der Donk C; Kroon AA; Ferreira I; Stehouwer CD; Hackeng TM; Pinto-Sietsma SJ
    Eur J Prev Cardiol; 2012 Dec; 19(6):1465-73. PubMed ID: 21914686
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between the metabolic syndrome and parental history of premature cardiovascular disease.
    Dallongeville J; Grupposo MC; Cottel D; Ferrières J; Arveiler D; Bingham A; Ruidavets JB; Haas B; Ducimetière P; Amouyel P
    Eur Heart J; 2006 Mar; 27(6):722-8. PubMed ID: 16401673
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of conventional and novel mechanisms in explaining increased risk of cardiovascular events in offspring with positive parental history.
    Hamer M; Chida Y; Stamatakis E
    J Hypertens; 2009 Oct; 27(10):1966-71. PubMed ID: 19587606
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of fenofibrate on cardiovascular events in patients with diabetes, with and without prior cardiovascular disease: The Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study.
    Tonkin A; Hunt D; Voysey M; Kesäniemi A; Hamer A; Waites J; Mahar L; Mann S; Glasziou P; Forder P; Simes J; Keech AC;
    Am Heart J; 2012 Mar; 163(3):508-14. PubMed ID: 22424024
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-aspirin NSAIDs, cyclooxygenase-2 inhibitors and risk for cardiovascular events-stroke, acute myocardial infarction, and death from coronary heart disease.
    Roumie CL; Choma NN; Kaltenbach L; Mitchel EF; Arbogast PG; Griffin MR
    Pharmacoepidemiol Drug Saf; 2009 Nov; 18(11):1053-63. PubMed ID: 19637402
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of traditional and novel risk factors on the relationship between socioeconomic status and incident cardiovascular events.
    Albert MA; Glynn RJ; Buring J; Ridker PM
    Circulation; 2006 Dec; 114(24):2619-26. PubMed ID: 17116764
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The influence of pre-operative electrocardiographic abnormalities and cardiovascular risk factors on patient and graft survival following renal transplantation.
    Woo YM; McLean D; Kavanagh D; Ward L; Aitken S; Miller GJ; Egan P; Hughes K; Clark L; Carswell K; Morris ST; Northridge DB; Rodger RS; Jardine AG
    J Nephrol; 2002; 15(4):380-6. PubMed ID: 12243367
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exercise and cardiovascular outcomes by hypertensive status: NHANES I epidemiological follow-up study, 1971-1992.
    Fang J; Wylie-Rosett J; Alderman MH
    Am J Hypertens; 2005 Jun; 18(6):751-8. PubMed ID: 15925731
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The association between fibrate use, change in high-density lipoprotein cholesterol, and the risk of cardiovascular disease: a retrospective chart review involving up to 8 years of follow-up.
    Nichols GA; Koro CE; Chan W; Bowlin SJ; Sprecher DL
    Clin Ther; 2006 Feb; 28(2):243-50. PubMed ID: 16678645
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complement factor H Y402H decreases cardiovascular disease risk in patients with familial hypercholesterolaemia.
    Koeijvoets KC; Mooijaart SP; Dallinga-Thie GM; Defesche JC; Steyerberg EW; Westendorp RG; Kastelein JJ; van Hagen PM; Sijbrands EJ
    Eur Heart J; 2009 Mar; 30(5):618-23. PubMed ID: 19098018
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Young women with PAD are at high risk of cardiovascular complications.
    Wisman PP; Tangelder MJ; van Hattum ES; de Borst GJ; Moll FL
    Eur J Vasc Endovasc Surg; 2012 Apr; 43(4):441-5. PubMed ID: 22289611
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The association between educational level and risk of cardiovascular disease fatality among women with cardiovascular disease.
    Lee JR; Paultre F; Mosca L
    Womens Health Issues; 2005; 15(2):80-8. PubMed ID: 15767198
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiovascular events associated with the use of four nonselective NSAIDs (etodolac, nabumetone, ibuprofen, or naproxen) versus a cyclooxygenase-2 inhibitor (celecoxib): a population-based analysis in Taiwanese adults.
    Huang WF; Hsiao FY; Wen YW; Tsai YW
    Clin Ther; 2006 Nov; 28(11):1827-36. PubMed ID: 17213003
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship between lung function impairment and incidence or recurrence of cardiovascular events in a middle-aged cohort.
    Johnston AK; Mannino DM; Hagan GW; Davis KJ; Kiri VA
    Thorax; 2008 Jul; 63(7):599-605. PubMed ID: 18245145
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protease inhibitor exposure and increased risk of cardiovascular disease in HIV-infected patients.
    Iloeje UH; Yuan Y; L'italien G; Mauskopf J; Holmberg SD; Moorman AC; Wood KC; Moore RD
    HIV Med; 2005 Jan; 6(1):37-44. PubMed ID: 15670251
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Perceived stress and cardiovascular disease mortality. The Ohsaki Cohort Study].
    Kowata E; Hozawa A; Kakizaki M; Tomata Y; Nagai M; Sugawara Y; Kuriyama S; Tsuji I
    Nihon Koshu Eisei Zasshi; 2012 Feb; 59(2):82-91. PubMed ID: 22642183
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipoprotein(a) and family history of cardiovascular disease in children with familial dyslipidemias.
    Guardamagna O; Abello F; Anfossi G; Pirro M
    J Pediatr; 2011 Aug; 159(2):314-9. PubMed ID: 21392785
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic variants in TGFβ-1 and PAI-1 as possible risk factors for cardiovascular disease after radiotherapy for breast cancer.
    Hilbers FS; Boekel NB; van den Broek AJ; van Hien R; Cornelissen S; Aleman BM; van 't Veer LJ; van Leeuwen FE; Schmidt MK
    Radiother Oncol; 2012 Jan; 102(1):115-21. PubMed ID: 22100658
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of cytomegalovirus sero-status in the development of secondary cardiovascular events in patients with coronary heart disease under special consideration of diabetes.
    Guech-Ongey M; Brenner H; Twardella D; Hahmann H; Rothenbacher D
    Int J Cardiol; 2006 Jul; 111(1):98-103. PubMed ID: 16229909
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.